UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

lloprost delivered via the BREELIBTM nebulizer: a review of the clinical evidence for efficacy and safety

Therapeutic Advances in Respiratory Disease, 2019-03, Vol.13, p.1753466619835497-1753466619835497

Gessler, Tobias

2019

Volltextzugriff (PDF)

lloprost delivered via the BREELIB nebulizer: a review of the clinical evidence for efficacy and safety

Therapeutic advances in respiratory disease, 2019-03, Vol.13

Tobias Gessler

2019

Volltextzugriff (PDF)

Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery

Journal of controlled release, 2012-03, Vol.158 (2), p.329-335

2012

Volltextzugriff (PDF)

Inhalation of repurposed drugs to treat pulmonary hypertension

Advanced drug delivery reviews, 2018-08, Vol.133, p.34-44

Gessler, Tobias

2018

Volltextzugriff (PDF)

Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome

American journal of respiratory and critical care medicine, 2014-03, Vol.189 (5), p.609-611

2014

Volltextzugriff (PDF)

Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro

Nanomedicine, 2011-06, Vol.7 (3), p.341-350

2011

Volltextzugriff (PDF)

Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles

Journal of controlled release, 2016-03, Vol.226, p.15-20

2016

Volltextzugriff (PDF)

Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension

Nanomedicine, 2016-01, Vol.12 (1), p.63-68

2016

Volltextzugriff (PDF)

The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension

Therapeutic Advances in Respiratory Disease, 2011-06, Vol.5 (3), p.195-206

2011

Volltextzugriff (PDF)

Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.)

Current pharmaceutical design, 2016-03, Vol.22 (9), p.1147

2016

Volltextzugriff (PDF)

lloprost delivered via the BREELIB TM nebulizer: a review of the clinical evidence for efficacy and safety

Therapeutic advances in respiratory disease, 2019-01, Vol.13, p.175346661983549

Gessler, Tobias

2019

Volltextzugriff (PDF)

Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs

The journal of gene medicine, 2008-11, Vol.10 (11), p.1236-1246

2008

Volltextzugriff (PDF)

Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

Journal of controlled release, 2003-01, Vol.86 (1), p.131-144

2003

Volltextzugriff (PDF)

Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models

Journal of nanomaterials, 2011-01, Vol.2011, p.1-16

2011

Volltextzugriff (PDF)

Pharmacodynamics and Pharmacokinetics of Inhaled Iloprost, Aerosolized by Three Different Devices, in Severe Pulmonary Hypertension

Chest, 2003-10, Vol.124 (4), p.1294-1304

2003

Volltextzugriff (PDF)

lloprost delivered via the BREELIB TM nebulizer: a review of the clinical evidence for efficacy and safety

Therapeutic advances in respiratory disease, 2019-01, Vol.13, p.1753466619835497

Gessler, Tobias

2019

Volltextzugriff (PDF)

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension

Pulmonary circulation, 2017-04, Vol.7 (2), p.505-513

2017

Volltextzugriff (PDF)

Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery

Journal of drug targeting, 2009-09, Vol.17 (8), p.638-651

2009

Volltextzugriff (PDF)

Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb ® Pro: Formulation aspects and nanoparticle stability to nebulization

International journal of pharmaceutics, 2012-01, Vol.422 (1), p.398-408

2012

Volltextzugriff (PDF)

Development of a biodegradable nanoparticle platform for sildenafil: Formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters

Journal of controlled release, 2012-02, Vol.157 (3), p.469-477

2012

Volltextzugriff (PDF)

Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations

European journal of pharmaceutics and biopharmaceutics, 2013-05, Vol.84 (1), p.106-114

2013

Volltextzugriff (PDF)

Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model

International journal of pharmaceutics, 2009-02, Vol.367 (1), p.169-178

2009

Volltextzugriff (PDF)

Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension : Formulation aspects and stability

Pharmaceutical research, 2007-02, Vol.24 (2), p.277-287

2007

Volltextzugriff (PDF)

Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells

Journal of controlled release, 2009-11, Vol.140 (1), p.47-54

2009

Volltextzugriff (PDF)

Novel 'Nano in Nano' Composites for Sustained Drug Delivery: Biodegradable Nanoparticles Encapsulated into Nanofiber Non-Wovens

Macromolecular bioscience, 2010-12, Vol.10 (12), p.1527-1535

2010

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(42)
Pharmacology & Pharmacy
(18)
Administration, Inhalation
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Animals
(15)
Humans
(14)
Aerosols
(13)
Particle Size
(12)
Pharmacology. Drug Treatments
(12)
General Pharmacology
(11)
Nebulizers And Vaporizers
(11)
Pharmaceutical Technology. Pharmaceutical Industry
(11)
Pulmonary Hypertension
(11)
Hypertension, Pulmonary - Drug Therapy
(10)
Nanoparticles
(10)
Physical Sciences
(10)
Respiratory System
(10)
Chemistry
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

lloprost delivered via the BREELIBTM nebulizer: a review of the clinical evidence for efficacy and safety

lloprost delivered via the BREELIB nebulizer: a review of the clinical evidence for efficacy and safety

Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery

Inhalation of repurposed drugs to treat pulmonary hypertension

Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome

Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro

Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles

Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension

The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension

Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.)

lloprost delivered via the BREELIB TM nebulizer: a review of the clinical evidence for efficacy and safety

Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs

Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models

Pharmacodynamics and Pharmacokinetics of Inhaled Iloprost, Aerosolized by Three Different Devices, in Severe Pulmonary Hypertension

lloprost delivered via the BREELIB TM nebulizer: a review of the clinical evidence for efficacy and safety

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension

Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery

Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb ® Pro: Formulation aspects and nanoparticle stability to nebulization

Development of a biodegradable nanoparticle platform for sildenafil: Formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters

Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations

Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model

Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension : Formulation aspects and stability

Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells

Novel 'Nano in Nano' Composites for Sustained Drug Delivery: Biodegradable Nanoparticles Encapsulated into Nanofiber Non-Wovens

Suchergebnisse filtern